$HTFL News

Reported October 22, 2026: 'Heartflow Says Elucid Stole Trade Secrets, Infringed Patents' - Bloomberg Law

Piper Sandler Reiterates Overweight on HeartFlow, Raises Price Target to $64

Heartflow to Report Third Quarter 2026 Financial Results on November 12, 2026

AI Cardiac Diagnostics Pioneer Sets HeartFlow (HTFL) for High-Margin Expansion

Canaccord Genuity Maintains Buy on HeartFlow, Raises Price Target to $56

BCSM Exits Heartflow (HTFL) on Competitive Concerns

HeartFlow's CEO Sells 38,900 Shares for $1.8 Million After the Stock Hit a 52-Week High

HeartFlow, Inc. (HTFL) Presents at Wells Fargo 21st Annual Healthcare Conference - Slideshow

UBS Initiates Coverage On HeartFlow with Neutral Rating, Announces Price Target of $55

HeartFlow CFO Dumps Over 33,000 Shares for $1.7 Million as the Stock Hits a 52-Week High

Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half

Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference

HeartFlow's Chief Medical Officer Sells 9,219 Shares Amid a Soaring Stock Price. What Does That Mean for Investors?

Heartflow (HTFL) Rockets 46%: What Analysts Say and Where Hedge Funds Stand

Is HeartFlow (HTFL) Already Overvalued Or Still Worth The Hype?

HeartFlow (HTFL) Jumps On Q2 Results As Raised Outlook Leaves Shares Fully Valued

HeartFlow (HTFL) Stock Gets Fair Value Boost After Q2 Beat And Guidance Raise

Analysts Are Bullish on Heartflow (HTFL) Stock. Here’s Why

Why Heartflow Stock Soared Today

This AI-Tied IPO Stock Just Broke Out On Its 'Outsized' Guidance Boost